Top

Published in:

01-07-2019 | Influenza Virus | Original Article

Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins

Authors: P. G. Alexyuk, A. P. Bogoyavlenskiy, M. S. Alexyuk, A. S. Turmagambetova, I. A. Zaitseva, E. S. Omirtaeva, V. E. Berezin

Published in: Archives of Virology | Issue 7/2019

Abstract

Numerous studies have shown that immunostimulatory complexes containing Quil-A saponin and various antigens are effective in stimulating the immune response and can be used as vaccine preparations for animals and humans. However, Quil-A saponin possesses toxicity and haemolytic activity. In the present work, a saponin-containing preparation named “Glabilox” was isolated from the roots of a Glycyrrhiza glabra L. plant by high-performance liquid chromatography (HPLC). The results showed that Glabilox has no toxicity or haemolytic activity and can form stable immunostimulatory complexes. Subcutaneous immunization of mice with an immunostimulating complex containing Glabilox and H7N1 influenza virus antigens stimulated high levels of humoral and cellular immunity. Vaccination of chickens with the same immunostimulating complex protected 100% of the animals after experimental infection with a homologous virus. Comparative studies showed that the immunogenic and protective activity of immunostimulatory complexes containing Quil-A and immunostimulatory complexes containing Glabilox are comparable to each other. The results of these studies indicated that Glycyrrhiza glabra saponins show great promise as safe and effective adjuvants.

WHO (2018) World health statistics 2018: monitoring health for the SDGs, sustainable development goals. World Health Organization, Geneva

Lim SS et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224–2260. https://doi.org/10.1016/S0140-6736(12)61766-8 CrossRefPubMedPubMedCentral

Armstrong-Mensah EA, Ndiaye SM (2018) Global health security agenda implementation: a case for community engagement. Health Secur 16(4):217–223. https://doi.org/10.1089/hs.2017.0097 CrossRefPubMed

Hoff NA, Doshi RH, Colwell B et al (2017) Evolution of a disease surveillance system: an increase in reporting of human monkeypox disease in the Democratic Republic of the Congo, 2001–2013. Int J Trop Dis Health. https://doi.org/10.9734/ijtdh/2017/35885 CrossRefPubMedPubMedCentral

De Gregorio E, Rappuoli R (2012) Vaccines for the future: learning from human immunology. Microb Biotechnol 5:149–155. https://doi.org/10.1111/j.1751-7915.2011.00276.x CrossRefPubMedPubMedCentral

Delany I, Rappuoli R, De Gregorio E (2014) Vaccines for the 21st century. EMBO Mol Med 6:708–720. https://doi.org/10.1002/emmm.201403876 CrossRefPubMedPubMedCentral

Wan Z, Cardenas Garcia S, Liu J et al (2018) An alternative strategy as a quadrivalent live attenuated influenza virus vaccine. J Virol. https://doi.org/10.1128/jvi.01025-18 CrossRefPubMedPubMedCentral

Arvin AM, Greenberg HB (2006) New viral vaccines. Virology 344:240–249CrossRefPubMed

Wang S, Liu H, Zhang X, Qian F (2015) Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies. Protein Cell 6(7):480–503. https://doi.org/10.1007/s13238-015-0164-2 CrossRefPubMedPubMedCentral

10.

Pollard AJ (2007) New combination vaccines still need a boost. Arch Dis Child 92:1–2CrossRefPubMedPubMedCentral

11.

Poland GA, Whitaker JA, Poland CM et al (2016) Vaccinology in the third millennium: scientific and social challenges. Curr Opin Virol 17:116–125. https://doi.org/10.1016/j.coviro.2016.03.003 CrossRefPubMedPubMedCentral

12.

Saso A, Kampmann B (2017) Vaccine responses in newborns. Semin Immunopathol 39:627–642. https://doi.org/10.1007/s00281-017-0654-9 CrossRefPubMedPubMedCentral

13.

Dreskin SC, Halsey NA, Kelso JM et al (2016) International Consensus (ICON): allergic reactions to vaccines. World Allergy Organ J 9:32. https://doi.org/10.1186/s40413-016-0120-5 CrossRefPubMedPubMedCentral

14.

Azmi F, Ahmad Fuaad AA, Skwarczynski M, Toth I (2014) Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother 10:778–796CrossRefPubMed

15.

Mohan T, Verma P, Rao DN (2013) Novel adjuvants and delivery vehicles for vaccines development: a road ahead. Indian J Med Res 138:779–795PubMedPubMedCentral

16.

Rajput ZI, Hu S, Xiao C, Arijo AG (2007) Adjuvant effects of saponins on animal immune responses. J Zhejiang Univ Sci B 8:153–161. https://doi.org/10.1631/jzus.2007.B0153 CrossRefPubMedPubMedCentral

17.

Marciani DJ (2018) Elucidating the mechanisms of action of saponin-derived adjuvants. Trends Pharmacol Sci 39:573–585. https://doi.org/10.1016/j.tips.2018.03.005 CrossRefPubMed

18.

Zhao YC, Xue CH, Zhang TT, Wang YM (2018) Saponins from sea cucumber and their biological activities. J Agric Food Chem 66:7222–7237. https://doi.org/10.1021/acs.jafc.8b01770 CrossRefPubMed

19.

Morein B, Hu KF, Abasugra I (2004) Current status and potential application of ISCOMs in veterinary medicine. Adv Drug Deliv Rev 56:1367–1382CrossRefPubMed

20.

Mowat AM, Donachie AM, Reid G, Jarrett O (1991) Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 72:317–322PubMedPubMedCentral

21.

Sun HX, Xie Y, Ye YP (2009) ISCOMs and ISCOMATRIX. Vaccine 27:4388–4401. https://doi.org/10.1016/j.vaccine.2009.05.032 CrossRefPubMed

22.

White K, RadesT Kearns P, Toth I, Hook S (2006) Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res 23:1473–1481CrossRefPubMed

23.

Zhu D, Tuo W (2016) QS-21: a potent vaccine adjuvant. Nat Prod Chem Res 3(4):e113. https://doi.org/10.4172/2329-6836.1000e113 CrossRef

24.

Brügmann M, Drommer W, Reichl U, Boge A (1997) ISCOM (Immuno Stimulating Complex)-vaccine of equine influenza virus–transmission electron microscopic investigation and literature review. DTW 104(6):196–202

25.

Sjölander A, Cox JC, Barr IG (1999) ISCOMs: an adjuvant with multiple functions. J Leukoc Biol 64:713–723CrossRef

26.

Chung KY, Coyle EM, Jani D et al (2015) ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans. Vaccine 33:3953–3962CrossRefPubMed

27.

Hägglund S, Hu K, Blodörn K et al (2014) Characterization of an experimental vaccine for bovine respiratory syncytial virus. Clin Vaccine Immunol 21:997–1004CrossRefPubMedPubMedCentral

28.

Fossum C, Hjertner B, Ahlberg V et al (2014) Early inflammatory response to the saponin adjuvant Matrix-M in the pig. Vet Immunol Immunopathol 158:53–61CrossRefPubMed

29.

Magnusson SE, Karlsson KH, Reimer JM et al (2014) Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice. Vaccine 32:800–808CrossRefPubMed

30.

(2007) New smallpox vaccine approved by US FDA. Expert Rev Vaccines 6(5):654–655. https://doi.org/10.1586/14760584.6.5.653

31.

Berezin VE, Zaides VM, Isaeva ES, Artamonov AF, Zhdanov VM (1988) Controlled organization of multimolecular complexes of enveloped virus glycoproteins: study of immunogenicity. Vaccine 6:450–456CrossRefPubMed

32.

Klimov A, Balish A, Veguilla V et al (2012) Influenza virus titration, antigenic characterization, and serological methods for antibody detection. Methods Mol Biol 865:25–51. https://doi.org/10.1007/978-1-61779-621-0_3 CrossRefPubMed

33.

Carlsson N, Borde A, Wölfel S, Åkerman B, Larsson A (2011) Quantification of protein concentration by the Bradford method in the presence of pharmaceutical polymers. Anal Biochem 411:116–121CrossRefPubMed

34.

Fontan Candela JL (1958) Methodes analytiques de différenciation des saponines. Bulletin de la Société de chimie biologique 40:503–510PubMed

35.

Bomford R (1980) Saponin and other haemolysins (vitamin A, aliphatic amines, polyene antibiotics) as adjuvants for SRBC in the mouse. Evidence for a role for cholesterol-binding in saponin adjuvanticity. Int Arch Allergy Appl Immunol 63(2):170–177CrossRefPubMed

36.

Ozel M, Hoglund S, Gelderblom H, Morein B (1989) Quaternary structure of the immunostimulating complex (ISCOM). J Ultrastruct Mol Struct Res 102:240–248CrossRefPubMed

37.

Natarajan S, Remick DG (2013) ELISA rescue protocol: recovery of sample concentrations from an assay with an unsuccessful standard curve. Methods 61:69–72CrossRefPubMed

38.

Verschoor CP, Singh P, Russell ML et al (2016) Correction: microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children. PLoS One 11(9):e0163830CrossRefPubMedPubMedCentral

39.

Allison AC (1998) The mode of action of immunological adjuvants. Dev Biol Stand 92:3–11PubMed

40.

Aucouturier J, Ganne V, Laval A (2000) Efficacy and safety of new adjuvants. Ann N Y Acad Sci 916:600–604CrossRefPubMed

41.

Lee S, Nguyen MT (2015) Recent advances of vaccine adjuvants for infectious diseases. Immune Netw 15:51–57. https://doi.org/10.4110/in.2015.15.2.51 CrossRefPubMedPubMedCentral

42.

Di Pasquale A, Preiss S, Da Silva FT, Garçon N (2015) Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines (Basel) 3:320–343. https://doi.org/10.3390/vaccines3020320 CrossRef

43.

Hu KF, Regner M, Siegrist CA et al (2005) The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703. FEMS Immunol Med Microbiol 43:269–276CrossRefPubMed

44.

Kitagawa I (2002) Licorice root. A natural sweetener and an important ingredient in Chinese medicine. Pure Appl Chem 74:1189–1198CrossRef

45.

Schmid C, Dawid C, Peters V, Hofmann T (2018) Saponins from European Licorice Roots (Glycyrrhiza glabra). J Nat Prod 81:1734–1744. https://doi.org/10.1021/acs.jnatprod.8b00022 CrossRefPubMed

46.

Zhang Q, Ye M (2009) Chemical analysis of the Chinese herbal medicine Gan-Cao (licorice). J Chromatogr A 1216:1954–1969. https://doi.org/10.1016/j.chroma.2008.07.072 CrossRefPubMed

47.

Sun HX, Xie Y, Ye YP (2009) Advances in saponin-based adjuvants. Vaccine 27:1787–1796. https://doi.org/10.1016/j.vaccine.2009.01.091 CrossRef

48.

Silveira F, Cibulski SP, Varela AP et al (2011) Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation. Vaccine 29:9177–9182. https://doi.org/10.1016/j.vaccine.2011.09.1 CrossRefPubMed

Title: Adjuvant activity of multimolecular complexes based on Glycyrrhiza glabra saponins, lipids, and influenza virus glycoproteins
Authors: P. G. Alexyuk
A. P. Bogoyavlenskiy
M. S. Alexyuk
A. S. Turmagambetova
I. A. Zaitseva
E. S. Omirtaeva
V. E. Berezin
Publication date: 01-07-2019
Publisher: Springer Vienna
Keyword: Influenza Virus
Published in: Archives of Virology / Issue 7/2019
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-019-04273-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2019

Development of a duplex reverse transcription recombinase-aided amplification assay for respiratory syncytial virus incorporating an internal control

Faba bean polerovirus 1 (FBPV-1); a new polerovirus infecting legume crops in Australia

Characterization and detection of a new badnavirus infecting Epiphyllum spp.

Genomic sequence of a Bohle iridovirus strain isolated from a diseased boreal toad (Anaxyrus boreas boreas) in a North American aquarium

Schmallenberg virus in Azerbaijan 2012–2018

Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage